David Fassler, M.D. ’82, clinical associate professor of psychiatry at the University of Vermont College of Medicine, testified before the Psychopharmacologic Drugs Advisory Committee of the Food and Drug Administration in February on behalf of the American Psychiatric Association (APA). Fassler, a trustee of the APA and vice chair of the Assembly of the American Academy of Child and Adolescent Psychiatry (AACAP), addressed the diagnosis and treatment of childhood and adolescent depression and the safety and efficacy of anti-depressant medication. At the request of the American Bar Association, he also testified before legislatures in Nevada, New Hampshire and Wyoming on bills to eliminate juvenile executions. Fassler helped draft and pass the APA and AACAP position statements on the juvenile death penalty, based on scientific evidence concerning adolescent brain development.